SNDX FY 2018 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

SNDXSyndax Pharmaceuticals, Inc.

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-28.0% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$76M-5001.7% margin

Net Income

-$74M-4875.5% margin

EPS (Diluted)

$-2.92

Cash Flow

Operating Cash Flow

-$69M

Free Cash Flow

-$69M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$84M

Total Liabilities

$31M

Stockholders' Equity

$53M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-28.0%
Gross Profit	$2M	$2M	-28.0%
Operating Income	-$76M	-$62M	-22.5%
Net Income	-$74M	-$61M	-21.6%